Kang, Eun-Young; Millstein, Joshua; Popovic, Gordana; Meagher, Nicola S.; Bolithon, Adelyn; Talhouk, Aline; Chiu, Derek S.; Anglesio, Michael S.; Leung, Betty; Tang, Katrina; Lambie, Neil; Pavanello, Marina; Ramus, Susan J.; Köbel, Martin; Reis, Francisco José Candido dos 
Source: Virchows Archiv. Unidade: FMRP
Subjects: BIOMARCADORES, PROLIFERAÇÃO CELULAR, NEOPLASIAS OVARIANAS, RNA MENSAGEIRO, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANG, Eun-Young et al. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, v. 480, n. 4, p. 855-871, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00428-021-03232-0. Acesso em: 30 ago. 2024.APA
Kang, E. -Y., Millstein, J., Popovic, G., Meagher, N. S., Bolithon, A., Talhouk, A., et al. (2022). MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Archiv, 480( 4), 855-871. doi:10.1007/s00428-021-03232-0NLM
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1007/s00428-021-03232-0Vancouver
Kang E-Y, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Ramus SJ, Köbel M, Reis FJC dos. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma [Internet]. Virchows Archiv. 2022 ; 480( 4): 855-871.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1007/s00428-021-03232-0
